1. Home
  2. LINK vs PMN Comparison

LINK vs PMN Comparison

Compare LINK & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Interlink Electronics Inc.

LINK

Interlink Electronics Inc.

N/A

Current Price

$3.27

Market Cap

64.7M

Sector

Technology

ML Signal

N/A

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

N/A

Current Price

$4.07

Market Cap

84.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LINK
PMN
Founded
1984
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
64.7M
84.1M
IPO Year
2007
2022

Fundamental Metrics

Financial Performance
Metric
LINK
PMN
Price
$3.27
$4.07
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
N/A
★ $42.27
AVG Volume (30 Days)
21.0K
★ 350.4K
Earning Date
11-24-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 45.83
N/A
EPS
★ N/A
N/A
Revenue
★ $11,890,000.00
N/A
Revenue This Year
$40.45
N/A
Revenue Next Year
$19.16
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 1.81
N/A
52 Week Low
$2.66
$0.29
52 Week High
$6.50
$27.40

Technical Indicators

Market Signals
Indicator
LINK
PMN
Relative Strength Index (RSI) 30.80 32.67
Support Level $2.87 $2.78
Resistance Level $3.38 $15.05
Average True Range (ATR) 0.30 1.21
MACD -0.05 -0.26
Stochastic Oscillator 20.13 13.58

Price Performance

Historical Comparison
LINK
PMN

About LINK Interlink Electronics Inc.

Interlink Electronics Inc is a provider of sensing technologies and printed electronics solutions that enable Human-Machine Interface (HMI) devices and Internet-of-Things (IoT) applications. Its broad product and technology portfolio spans force and touch sensors, piezoelectric sensors, rugged HMI sensors, wearable and textile-based sensors and electrochemical gas and environmental sensors, along with instruments and fully integrated systems based on its sensor technologies. It serves blue-chip customers and emerging companies across diverse end-use markets, including medical, industrial, automotive, consumer electronics, wearables, environmental monitoring, and specialty applications. It operates in single segment: the design, development, and manufacture of sensor technologies.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimers disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Compnies product candidates are PMN310, PMN267, and PMN442. Lead product candidate is PMN310, a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 is companies second lead product candidate targeting ALS.

Share on Social Networks: